SCNX
Scienture Holdings, Inc.NASDAQHealthcare$0.33+10.26%ClosedMarket Cap: $5.0M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
11.67
EV/EBITDA
170.37
DCF Value
$41.86
FCF Yield
-265738.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.2%
Operating Margin
-10079976.7%
Net Margin
-9618025.6%
ROE
-236.0%
ROA
-49.3%
ROIC
-53.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $-168.7K | -196152.3% | $-43.49B | $-41.50B | $-1.70 | — |
| FY 2025 | $431.6K | 76801.5% | $-43.51B | $-41.51B | $-2.70 | — |
| Q3 2025 | $590.0K | 97.4% | $-3.6M | $-3.6M | $-0.19 | — |
| Q2 2025 | $0.00 | -Infinity% | $-5.2M | $-6.7M | $-0.48 | — |
| Q1 2025 | $10.3K | 6.6% | $-3.6M | $-3.1M | $-0.33 | — |
| Q4 2024 | $53.1K | 5.3% | $-4.2M | $-7.2M | $-0.82 | — |
| FY 2024 | $136.6K | 4.4% | $-14.7M | $9.1M | $2.48 | $9.50 |
| Q3 2024 | $64.9K | 6.0% | $-3.5M | $-3.2M | $-1.34 | $1.50 |
| Q2 2024 | $18.7K | -3.8% | $-1.5M | $-1.8M | $-0.77 | — |
| Q1 2024 | $0.00 | -Infinity% | $-5.5M | $-8.4M | $-6.66 | $8.00 |
| Q4 2023 | $2.4M | -95.6% | $-6.2M | $-11.7M | $-4.93 | — |
| FY 2023 | $1.4M | 3.6% | $-4.4M | $-17.8M | $-7.49 | — |